Clostridium perfringens epsilon toxin mutant Y30A-Y196A as a recombinant vaccine candidate against enterotoxemia

Vaccine

Volumn 32, Issue 23, 2014, Pages 2682-2687

  Bokori Brown, Monika ^a   Hall, Charlotte A ^a   Vance, Charlotte ^a   Fernandes da Costa, Sérgio P ^a   Savva, Christos G ^b   Naylor, Claire E ^b   Cole, Ambrose R ^b   Basak, Ajit K ^b   Moss, David S ^b   Titball, Richard W ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Clostridium perfringens; Enterotoxemia; Epsilon toxin pore forming toxin; Recombinant vaccine

Indexed keywords

CLOSTRIDIUM TOXIN; POLYCLONAL ANTIBODY; RECOMBINANT VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM MUTANT; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; CYTOTOXICITY TEST; ENTEROTOXEMIA; FEMALE; IMMUNIZATION; MDCK CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; WILD TYPE;

CLOSTRIDIUM PERFRINGENS; ENTEROTOXEMIA; EPSILON TOXIN PORE-FORMING TOXIN; RECOMBINANT VACCINE;

ANIMALS; BACTERIAL TOXINS; BACTERIAL VACCINES; DOGS; ENTEROTOXEMIA; FEMALE; MADIN DARBY CANINE KIDNEY CELLS; MICE; MICE, INBRED BALB C; MUTAGENESIS, SITE-DIRECTED; NEUTRALIZATION TESTS; PROTEIN STRUCTURE, TERTIARY; RABBITS; RECOMBINANT PROTEINS; VACCINES, SYNTHETIC;

EID: 84899977403     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.03.079     Document Type: Article

References (23)

1. Petit L., Gibert M., Popoff M.R. Clostridium perfringens: toxinotype and genotype. Trends Microbiol. 1999, 7:104-110.
2. Songer J.G. Clostridial enteric diseases of domestic animals. Clin. Microbiol. Rev. 1996, 9:216-234.
3. Songer J.G. Clostridial Diseases of Animals 1997, Academic Press, San Diego.
4. Rumah K.R., Linden J., Fischetti V.A., Vartanian T. Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease. PLoS One 2013, 8:e76359.
5. Uzal F.A., Songer J.G. Diagnosis of Clostridium perfringens intestinal infections in sheep and goats. J. Vet. Diagn. Invest. 2008, 20:253-265.
6. Finnie J.W. Pathogenesis of brain damage produced in sheep by Clostridium perfringens type D epsilon toxin: a review. Aust. Vet. J. 2003, 81:219-221.
7. McDonel J.L. Clostridium perfringens toxins (type A, B, C, D, E). Pharmacol. Ther. 1980, 10:617-655.
8. Bhown A.S., Habeerb A.F. Structural studies on epsilon-prototoxin of Clostridium perfringens type D. Localization of the site of tryptic scission necessary for activation to epsilon-toxin. Biochem. Biophys. Res. Commun. 1977, 78:889-896.
9. Jin F., Matsushita O., Katayama S., Jin S., Matsushita C., Minami J., et al. Purification, characterization, and primary structure of Clostridium perfringens lambda-toxin, a thermolysin-like metalloprotease. Infect. Immun. 1996, 64:230-237.
10. Minami J., Katayama S., Matsushita O., Matsushita C., Okabe A. Lambda-toxin of Clostridium perfringens activates the precursor of epsilon-toxin by releasing its N- and C-terminal peptides. Microbiol. Immunol. 1997, 41:527-535.
11. Chandran D., Naidu S.S., Sugumar P., Rani G.S., Vijayan S.P., Mathur D., et al. Development of a recombinant epsilon toxoid vaccine against enterotoxemia and its use as a combination vaccine with live attenuated sheep pox virus against enterotoxemia and sheep pox. Clin. Vaccine Immunol. 2010, 17:1013-1016.
12. Lobato F.C., Lima C.G., Assis R.A., Pires P.S., Silva R.O., Salvarani F.M., et al. Potency against enterotoxemia of a recombinant Clostridium perfringens type D epsilon toxoid in ruminants. Vaccine 2010, 28:6125-6127.
13. Stokka G.L., Edwards A.J., Spire M.F., Brandt R.T., Smith J.E. Inflammatory response to clostridial vaccines in feedlot cattle. J. Am. Vet. Med. Assoc. 1994, 204:415-419.
14. Bokori-Brown M., Kokkinidou M.C., Savva C.G., Fernandes da Costa S., Naylor C.E., Cole A.R., et al. Clostridium perfringens epsilon toxin H149A mutant as a platform for receptor binding studies. Protein Sci. 2013, 22:650-659.
15. Ivie S.E., McClain M.S. Identification of amino acids important for binding of Clostridium perfringens epsilon toxin to host cells and to HAVCR1. Biochemistry 2012, 51:7588-7595.
16. Lavinder J.J., Hari S.B., Sullivan B.J., Magliery T.J. High-throughput thermal scanning: a general, rapid dye-binding thermal shift screen for protein engineering. J. Am. Chem. Soc. 2009, 131:3794-3795.
17. Oyston P.C.F., Payne D.W., Havard H.L., Williamson E.D., Titball R.W. Production of a non-toxic site-directed mutant of Clostridium perfringens epsilon-toxin which induces protective immunity in mice. Microbiology (UK) 1998, 144:333-341.
18. Li Q., Xin W., Gao S., Kang L., Wang J. A low-toxic site-directed mutant of Clostridium perfringens epsilon-toxin as a potential candidate vaccine against enterotoxemia. Hum Vaccines Immunother. 2013, 9.
19. Hildebrand A., Pohl M., Bhakdi S. Staphylococcus aureus alpha-toxin. Dual mechanism of binding to target cells. J. Biol. Chem. 1991, 266:17195-17200.
20. Miyamoto O., Sumitani K., Nakamura T., Yamagami S., Miyata S., Itano T., et al. Clostridium perfringens epsilon toxin causes excessive release of glutamate in the mouse hippocampus. FEMS Microbiol. Lett. 2000, 189:109-113.
21. Hirschberg H., Zhang M.J., Gach H.M., Uzal F.A., Peng Q., Sun C.H., et al. Targeted delivery of bleomycin to the brain using photo-chemical internalization of Clostridium perfringens epsilon prototoxin. J. Neurooncol. 2009, 95:317-329.
22. Worthington R.W., Mulders M.S. Physical changes in the epsilon prototoxin molecule of Clostridium perfringens during enzymatic activation. Infect. Immun. 1977, 18:549-551.
23. Gill D.M. Bacterial toxins: a table of lethal amounts. Microbiol. Rev. 1982, 46:86-94.